EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Activity
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

104 hedge funds and large institutions have $54M invested in Eagle Pharmaceuticals, Inc. in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 42 increasing their positions, 25 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
104
Holders Change
-3
Holders Change %
-2.8%
% of All Funds
1.52%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
42
Reduced
25
Closed
26
Calls
$522K
Puts
$58K
Net Calls
+$464K
Net Calls Change
+$463K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$2.25M
2
JGC
J. Goldman & Co
New York
+$1.29M
3
AQR Capital Management
AQR Capital Management
Connecticut
+$1.1M
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.04M
5
Bank of America
Bank of America
North Carolina
+$953K

Top Sellers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.89M
2
SGCIA
Smith Graham & Co Investment Advisors
Texas
-$4.31M
3
BIP
Brandes Investment Partners
California
-$2.04M
4
SI
Scout Investments
Missouri
-$2M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$1.91M
Name Holding Trade Value Shares
Change 		Shares
Change %
PNC Financial Services Group
126
PNC Financial Services Group
Pennsylvania
– -$237 -15 Closed
FMII
127
Farmers & Merchants Investments Inc
Nebraska
– -$110 -7 Closed
Toronto Dominion Bank
128
Toronto Dominion Bank
Ontario, Canada
– -$16 -1 Closed
2 3 4 5
6